Gene amplification, radiation sensitivity and DNA double-strand breaks

Mutation Research - Reviews in Mutation Research

Volumn 704, Issue 1-3, 2010, Pages 29-37

  Mondello, Chiara ^a   Smirnova, Alexandra ^b   Giulotto, Elena ^b  

^a CNR   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Cancer; DNA breaks; Gene amplification; Ionizing radiations

Indexed keywords

BCR ABL PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN P53; PROTEIN TYROSINE KINASE;

AMPLICON; CENTROMERE; DNA DAMAGE; DNA RECOMBINATION; DNA REPAIR; DNA STRAND BREAKAGE; DOUBLE STRANDED DNA BREAK; ENZYME ACTIVITY; GENE ACTIVATION; GENE AMPLIFICATION; GENE DUPLICATION; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENE REPLICATION; GENETIC TRANSFORMATION; HUMAN; IONIZING RADIATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; RADIOSENSITIVITY; REVIEW;

ANIMALS; DNA BREAKS, DOUBLE-STRANDED; DNA REPAIR; GENE AMPLIFICATION; GENOMIC INSTABILITY; HUMANS; RADIATION TOLERANCE; RADIATION, IONIZING;

EID: 77951977063     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrrev.2010.01.008     Document Type: Review

References (111)

1. Albertson D.G. Gene amplification in cancer. Trends Genet. 22 (2006) 447-455
2. Hattinger C.M., Stoico G., Michelacci F., Pasello M., Scionti I., Remondini D., Castellani G.C., Fanelli M., Scotlandi K., Picci P., and Serra M. Mechanisms of gene amplification and evidence of coamplification in drug-resistant human osteosarcoma cell lines. Genes Chromosomes Cancer 48 (2009) 289-309
3. Hamlin J.L., Milbrandt J.D., Heintz N.H., and Azizkhan J.C. DNA sequence amplification in mammalian cells. Int. Rev. Cytol. 90 (1984) 31-82
4. Stark G.R. Regulation and mechanisms of mammalian gene amplification. Adv. Cancer Res. 61 (1993) 87-113
5. Stark G.R., Debatisse M., Giulotto E., and Wahl G.M. Recent progress in understanding mechanisms of mammalian DNA amplification. Cell 57 (1989) 901-908
6. Emanuel B.S., and Saitta S.C. From microscopes to microarrays: dissecting recurrent chromosomal rearrangements. Nat. Rev. Genet. 8 (2007) 869-883
7. Myllykangas S., Bohling T., and Knuutila S. Specificity, selection and significance of gene amplifications in cancer. Semin. Cancer Biol. 17 (2007) 42-55
8. Brison O. Gene amplification and tumor progression. Biochim. Biophys. Acta 1155 (1993) 25-41
9. Schwab M. Oncogene amplification in solid tumors. Semin. Cancer Biol. 9 (1999) 319-325
10. Goker E., Waltham M., Kheradpour A., Trippett T., Mazumdar M., Elisseyeff Y., Schnieders B., Steinherz P., Tan C., Berman E., et al. Amplification of the dihydrofolate reductase gene is a mechanism of acquired resistance to methotrexate in patients with acute lymphoblastic leukemia and is correlated with p53 gene mutations. Blood 86 (1995) 677-684
11. Gorlick R., Goker E., Trippett T., Waltham M., Banerjee D., and Bertino J.R. Intrinsic and acquired resistance to methotrexate in acute leukemia. N. Engl. J. Med. 335 (1996) 1041-1048
12. Gorre M.E., Mohammed M., Ellwood K., Hsu N., Paquette R., Rao P.N., and Sawyers C.L. Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 293 (2001) 876-880
13. Wang T.L., Diaz Jr. L.A., Romans K., Bardelli A., Saha S., Galizia G., Choti M., Donehower R., Parmigiani G., Shih Ie M., Iacobuzio-Donahue C., Kinzler K.W., Vogelstein B., Lengauer C., and Velculescu V.E. Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 3089-3094
14. Zhang A., Zheng C., Lindvall C., Hou M., Ekedahl J., Lewensohn R., Yan Z., Yang X., Henriksson M., Blennow E., Nordenskjold M., Zetterberg A., Bjorkholm M., Gruber A., and Xu D. Frequent amplification of the telomerase reverse transcriptase gene in human tumors. Cancer Res. 60 (2000) 6230-6235
15. Takuma Y., Nouso K., Kobayashi Y., Nakamura S., Tanaka H., Matsumoto E., Fujikawa T., Suzuki M., Hanafusa T., and Shiratori Y. Telomerase reverse transcriptase gene amplification in hepatocellular carcinoma. J. Gastroenterol. Hepatol. 19 (2004) 1300-1304
16. Zhu C.Q., Cutz J.C., Liu N., Lau D., Shepherd F.A., Squire J.A., and Tsao M.S. Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer. Br. J. Cancer 94 (2006) 1452-1459
17. Savelyeva L., and Schwab M. Amplification of oncogenes revisited: from expression profiling to clinical application. Cancer Lett. 167 (2001) 115-123
18. King C.R., Kraus M.H., and Aaronson S.A. Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science 229 (1985) 974-976
19. Slamon D.J., Clark G.M., Wong S.G., Levin W.J., Ullrich A., and McGuire W.L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235 (1987) 177-182
20. Slamon D.J., Godolphin W., Jones L.A., Holt J.A., Wong S.G., Keith D.E., Levin W.J., Stuart S.G., Udove J., Ullrich A., et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244 (1989) 707-712
21. Carter P., Presta L., Gorman C.M., Ridgway J.B., Henner D., Wong W.L., Rowland A.M., Kotts C., Carver M.E., and Shepard H.M. Humanization of an anti-p185HER2 antibody for human cancer therapy. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 4285-4289
22. Al-Kuraya K., Schraml P., Torhorst J., Tapia C., Zaharieva B., Novotny H., Spichtin H., Maurer R., Mirlacher M., Kochli O., Zuber M., Dieterich H., Mross F., Wilber K., Simon R., and Sauter G. Prognostic relevance of gene amplifications and coamplifications in breast cancer. Cancer Res. 64 (2004) 8534-8540
23. Konopka J.B., Watanabe S.M., Singer J.W., Collins S.J., and Witte O.N. Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 1810-1814
24. Roh H.J., Shin D.M., Lee J.S., Ro J.Y., Tainsky M.A., Hong W.K., and Hittelman W.N. Visualization of the timing of gene amplification during multistep head and neck tumorigenesis. Cancer Res. 60 (2000) 6496-6502
25. Mottolese M., Nadasi E.A., Botti C., Cianciulli A.M., Merola R., Buglioni S., Benevolo M., Giannarelli D., Marandino F., Donnorso R.P., Venturo I., and Natali P.G. Phenotypic changes of p53, HER2, and FAS system in multiple normal tissues surrounding breast cancer. J. Cell Physiol. 204 (2005) 106-112
26. Tlsty T.D. Normal diploid human and rodent cells lack a detectable frequency of gene amplification. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 3132-3136
27. Wright J.A., Smith H.S., Watt F.M., Hancock M.C., Hudson D.L., and Stark G.R. DNA amplification is rare in normal human cells. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 1791-1795
28. Paulson T.G., Almasan A., Brody L.L., and Wahl G.M. Gene amplification in a p53-deficient cell line requires cell cycle progression under conditions that generate DNA breakage. Mol. Cell Biol. 18 (1998) 3089-3100
29. Livingstone L.R., White A., Sprouse J., Livanos E., Jacks T., and Tlsty T.D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70 (1992) 923-935
30. Yin Y., Tainsky M.A., Bischoff F.Z., Strong L.C., and Wahl G.M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70 (1992) 937-948
31. Alkan C., Kidd J.M., Marques-Bonet T., Aksay G., Antonacci F., Hormozdiari F., Kitzman J.O., Baker C., Malig M., Mutlu O., Sahinalp S.C., Gibbs R.A., and Eichler E.E. Personalized copy number and segmental duplication maps using next-generation sequencing. Nat. Genet. 41 (2009) 1061-1067
32. Prody C.A., Dreyfus P., Zamir R., Zakut H., and Soreq H. De novo amplification within a "silent" human cholinesterase gene in a family subjected to prolonged exposure to organophosphorous insecticides. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 690-694
33. van Ommen G.J. Frequency of new copy number variation in humans. Nat. Genet 37 (2005) 333-334
34. Hastings P.J., Lupski J.R., Rosenberg S.M., and Ira G. Mechanisms of change in gene copy number. Nat. Rev. Genet. 10 (2009) 551-564
35. Mefford H.C., and Eichler E.E. Duplication hotspots, rare genomic disorders, and common disease, Curr. Opin. Genet. Dev. 19 (2009) 196-204
36. Wei C., and Andrulis I.L. Overexpression of asparagine synthetase in albizziin-resistant murine diploid embryonic stem cells. Somat. Cell Mol. Genet 19 (1993) 321-330
37. Lefort N., Feyeux M., Bas C., Feraud O., Bennaceur-Griscelli A., Tachdjian G., Peschanski M., and Perrier A.L. Human embryonic stem cells reveal recurrent genomic instability at 20q11.21. Nat. Biotechnol 26 (2008) 1364-1366
38. Spits C., Mateizel I., Geens M., Mertzanidou A., Staessen C., Vandeskelde Y., Van der Elst J., Liebaers I., and Sermon K. Recurrent chromosomal abnormalities in human embryonic stem cells. Nat. Biotechnol 26 (2008) 1361-1363
39. Schimke R.T. Gene amplification in cultured cells. J. Biol. Chem. 263 (1988) 5989-5992
40. Hahn P., Nevaldine B., and Morgan W.F. X-ray induction of methotrexate resistance due to dhfr gene amplification. Somat. Cell Mol. Genet 16 (1990) 413-423
41. Mondello C., Guasconi V., Giulotto E., and Nuzzo F. Gamma-ray and hydrogen peroxide induction of gene amplification in hamster cells deficient in DNA double strand break repair. DNA Repair (Amst) 1 (2002) 483-493
42. Monteilhet C., Perrin A., Thierry A., Colleaux L., and Dujon B. Purification and characterization of the in vitro activity of I-Sce I, a novel and highly specific endonuclease encoded by a group I intron. Nucleic Acids Res. 18 (1990) 1407-1413
43. Pipiras E., Coquelle A., Bieth A., and Debatisse M. Interstitial deletions and intrachromosomal amplification initiated from a double-strand break targeted to a mammalian chromosome. Embo J. 17 (1998) 325-333
44. Glover T.W., Arlt M.F., Casper A.M., and Durkin S.G. Mechanisms of common fragile site instability. Hum. Mol Genet. 14 Spec No. 2 (2005) R197-205
45. Kuo M.T., Vyas R.C., Jiang L.X., and Hittelman W.N. Chromosome breakage at a major fragile site associated with P-glycoprotein gene amplification in multidrug-resistant CHO cells. Mol. Cell Biol. 14 (1994) 5202-5211
46. Bertoni L., Attolini C., Tessera L., Mucciolo E., and Giulotto E. Telomeric and nontelomeric (TTAGGG)n sequences in gene amplification and chromosome stability. Genomics 24 (1994) 53-62
47. Coquelle A., Pipiras E., Toledo F., Buttin G., and Debatisse M. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 89 (1997) 215-225
48. Debatisse M., Coquelle A., Toledo F., and Buttin G. Gene amplification mechanisms: the role of fragile sites. Recent Results Cancer Res. 154 (1998) 216-226
49. Hellman A., Zlotorynski E., Scherer S.W., Cheung J., Vincent J.B., Smith D.I., Trakhtenbrot L., and Kerem B. A role for common fragile site induction in amplification of human oncogenes. Cancer Cell 1 (2002) 89-97
50. Ciullo M., Debily M.A., Rozier L., Autiero M., Billault A., Mayau V., El Marhomy S., Guardiola J., Bernheim A., Coullin P., Piatier-Tonneau D., and Debatisse M. Initiation of the breakage-fusion-bridge mechanism through common fragile site activation in human breast cancer cells: the model of PIP gene duplication from a break at FRA7I. Hum. Mol. Genet. 11 (2002) 2887-2894
51. McClintock. The stability of broken ends of chromosomes in Zea mays. Genetics 26 (1941) 234-282
52. Toledo F., Smith K.A., Buttin G., and Debatisse M. The evolution of the amplified adenylate deaminase 2 domains in Chinese hamster cells suggests the sequential operation of different mechanisms of DNA amplification. Mutat. Res. 276 (1992) 261-273
53. Okuno Y., Hahn P.J., and Gilbert D.M. Structure of a palindromic amplicon junction implicates microhomology-mediated end joining as a mechanism of sister chromatid fusion during gene amplification. Nucleic Acids Res. 32 (2004) 749-756
54. Cahill D., Connor B., and Carney J.P. Mechanisms of eukaryotic DNA double strand break repair. Front. Biosci. 11 (2006) 1958-1976
55. Bignell G.R., Santarius T., Pole J.C., Butler A.P., Perry J., Pleasance E., Greenman C., Menzies A., Taylor S., Edkins S., Campbell P., Quail M., Plumb B., Matthews L., McLay K., Edwards P.A., Rogers J., Wooster R., Futreal P.A., and Stratton M.R. Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution. Genome Res. 17 (2007) 1296-1303
56. Smith K.A., Gorman P.A., Stark M.B., Groves R.P., and Stark G.R. Distinctive chromosomal structures are formed very early in the amplification of CAD genes in Syrian hamster cells. Cell 63 (1990) 1219-1227
57. Smith K.A., Stark M.B., Gorman P.A., and Stark G.R. Fusions near telomeres occur very early in the amplification of CAD genes in Syrian hamster cells. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 5427-5431
58. Lo A.W., Sabatier L., Fouladi B., Pottier G., Ricoul M., and Murnane J.P. DNA amplification by breakage/fusion/bridge cycles initiated by spontaneous telomere loss in a human cancer cell line. Neoplasia 4 (2002) 531-538
59. Tusell L., Soler D., Agostini M., Pampalona J., and Genesca A. The number of dysfunctional telomeres in a cell: one amplifies; more than one translocate. Cytogenet. Genome Res 122 (2008) 315-325
60. O'Driscoll M., and Jeggo P.A. The role of double-strand break repair-insights from human genetics. Nat. Rev. Genet. 7 (2006) 45-54
61. McVey M., and Lee S.E. MMEJ repair of double-strand breaks (director's cut): deleted sequences and alternative endings. Trends Genet 24 (2008) 529-538
62. Zha S., Boboila C., and Alt F.W. Mre11: roles in DNA repair beyond homologous recombination. Nat. Struct. Mol. Biol 16 (2009) 798-800
63. Trask B.J., and Hamlin J.L. Early dihydrofolate reductase gene amplification events in CHO cells usually occur on the same chromosome arm as the original locus. Genes Dev 3 (1989) 1913-1925
64. Toledo F., Buttin G., and Debatisse M. The origin of chromosome rearrangements at early stages of AMPD2 gene amplification in Chinese hamster cells. Curr. Biol 3 (1993) 255-264
65. Butler D.K., Yasuda L.E., and Yao M.C. Induction of large DNA palindrome formation in yeast: implications for gene amplification and genome stability in eukaryotes. Cell 87 (1996) 1115-1122
66. Ruiz J.C., and Wahl G.M. Formation of an inverted duplication can be an initial step in gene amplification. Mol. Cell Biol. 8 (1988) 4302-4313
67. Tanaka H., Tapscott S.J., Trask B.J., and Yao M.C. Short inverted repeats initiate gene amplification through the formation of a large DNA palindrome in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 8772-8777
68. Watanabe T., and Horiuchi T. A novel gene amplification system in yeast based on double rolling-circle replication. EMBO J. 24 (2005) 190-198
69. Tanaka H., Bergstrom D.A., Yao M.C., and Tapscott S.J. Widespread and nonrandom distribution of DNA palindromes in cancer cells provides a structural platform for subsequent gene amplification. Nat. Genet. 37 (2005) 320-327
70. Tanaka H., Cao Y., Bergstrom D.A., Kooperberg C., Tapscott S.J., and Yao M.C. Intrastrand annealing leads to the formation of a large DNA palindrome and determines the boundaries of genomic amplification in human cancer. Mol. Cell Biol. 27 (2007) 1993-2002
71. Haber J.E., and Debatisse M. Gene amplification: yeast takes a turn. Cell 125 (2006) 1237-1240
72. Windle B.E., and Wahl G.M. Molecular dissection of mammalian gene amplification: new mechanistic insights revealed by analyses of very early events. Mutat. Res. 276 (1992) 199-224
73. Nonet G.H., Carroll S.M., DeRose M.L., and Wahl G.M. Molecular dissection of an extrachromosomal amplicon reveals a circular structure consisting of an imperfect inverted duplication. Genomics 15 (1993) 543-558
74. Roelofs H., Tasseron-de Jong J.G., van der Wal-Aker J., Rodenburg R.J., van Houten G.B., van de Putte P., and Giphart-Gassler M. Gene amplification in a human osteosarcoma cell line results in the persistence of the original chromosome and the formation of translocation chromosomes. Mutat. Res. 276 (1992) 241-260
75. Coquelle A., Toledo F., Stern S., Bieth A., and Debatisse M. A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs. Mol. Cell 2 (1998) 259-265
76. Storlazzi C.T., Fioretos T., Surace C., Lonoce A., Mastrorilli A., Strombeck B., D'Addabbo P., Iacovelli F., Minervini C., Aventin A., Dastugue N., Fonatsch C., Hagemeijer A., Jotterand M., Muhlematter D., Lafage-Pochitaloff M., Nguyen-Khac F., Schoch C., Slovak M.L., Smith A., Sole F., Van Roy N., Johansson B., and Rocchi M. MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target gene. Hum. Mol. Genet. 15 (2006) 933-942
77. Collins V.P. Gene amplification in human gliomas. Glia 15 (1995) 289-296
78. Vogt N., Lefevre S.H., Apiou F., Dutrillaux A.M., Cor A., Leuraud P., Poupon M.F., Dutrillaux B., Debatisse M., and Malfoy B. Molecular structure of double-minute chromosomes bearing amplified copies of the epidermal growth factor receptor gene in gliomas. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 11368-11373
79. Windle B., Draper B.W., Yin Y.X., O'Gorman S., and Wahl G.M. A central role for chromosome breakage in gene amplification, deletion formation, and amplicon integration. Genes Dev. 5 (1991) 160-174
80. Biedler J.L., and Spengler B.A. A novel chromosome abnormality in human neuroblastoma and antifolate-resistant Chinese hamster cell lives in culture. J. Natl. Cancer Inst. 57 (1976) 683-695
81. Schwab M., Alitalo K., Klempnauer K.H., Varmus H.E., Bishop J.M., Gilbert F., Brodeur G., Goldstein M., and Trent J. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305 (1983) 245-248
82. Amler L.C., and Schwab M. Amplified N-myc in human neuroblastoma cells is often arranged as clustered tandem repeats of differently recombined DNA. Mol. Cell Biol. 9 (1989) 4903-4913
83. Kuwahara Y., Tanabe C., Ikeuchi T., Aoyagi K., Nishigaki M., Sakamoto H., Hoshinaga K., Yoshida T., Sasaki H., and Terada M. Alternative mechanisms of gene amplification in human cancers. Genes Chromosomes Cancer 41 (2004) 125-132
84. Singer M.J., Mesner L.D., Friedman C.L., Trask B.J., and Hamlin J.L. Amplification of the human dihydrofolate reductase gene via double minutes is initiated by chromosome breaks. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 7921-7926
85. Saito I., Groves R., Giulotto E., Rolfe M., and Stark G.R. Evolution and stability of chromosomal DNA coamplified with the CAD gene. Mol. Cell Biol. 9 (1989) 2445-2452
86. Miele M., Bonatti S., Menichini P., Ottaggio L., and Abbondandolo A. The presence of amplified regions affects the stability of chromosomes in drug-resistant Chinese hamster cells. Mutat. Res. 219 (1989) 171-178
87. Toledo F., Le Roscouet D., Buttin G., and Debatisse M. Co-amplified markers alternate in megabase long chromosomal inverted repeats and cluster independently in interphase nuclei at early steps of mammalian gene amplification. EMBO J. 11 (1992) 2665-2673
88. Sabatier L., Ricoul M., Pottier G., and Murnane J.P. The loss of a single telomere can result in instability of multiple chromosomes in a human tumor cell line. Mol. Cancer Res. 3 (2005) 139-150
89. Giulotto E., Knights C., and Stark G.R. Hamster cells with increased rates of DNA amplification, a new phenotype. Cell 48 (1987) 837-845
90. Tlsty T.D., White A., and Sanchez J. Suppression of gene amplification in human cell hybrids. Science 255 (1992) 1425-1427
91. Chernova O.B., Chernov M.V., Ishizaka Y., Agarwal M.L., and Stark G.R. MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-l-aspartate-treated cells, permitting CAD gene amplification. Mol. Cell Biol. 18 (1998) 536-545
92. Perry M.E., Commane M., and Stark G.R. Simian virus 40 large tumor antigen alone or two cooperating oncogenes convert REF52 cells to a state permissive for gene amplification. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 8112-8116
93. Giulotto E., Bertoni L., Attolini C., Rainaldi G., and Anglana M. BHK cell lines with increased rates of gene amplification are hypersensitive to ultraviolet light. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 3484-3488
94. Mondello C., Riboni R., Rady M., Giulotto E., and Nuzzo F. Gene amplification in Chinese hamster DNA repair deficient mutants. Mutat. Res. 346 (1995) 61-67
95. Chen S., Bigner S.H., and Modrich P. High rate of CAD gene amplification in human cells deficient in MLH1 or MSH6. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 13802-13807
96. Lin C.T., Lin W.H., Lyu Y.L., and Whang-Peng J. Inverted repeats as genetic elements for promoting DNA inverted duplication: implications in gene amplification. Nucleic Acids Res. 29 (2001) 3529-3538
97. Mondello C., Faravelli M., Pipitone L., Rollier A., Di Leonardo A., and Giulotto E. Gene amplification in fibroblasts from ataxia telangiectasia (AT) patients and in X-ray hypersensitive AT-like Chinese hamster mutants. Carcinogenesis 22 (2001) 141-145
98. Mondello C., Rebuzzini P., Dolzan M., Edmonson S., Taccioli G.E., and Giulotto E. Increased gene amplification in immortal rodent cells deficient for the DNA-dependent protein kinase catalytic subunit. Cancer Res. 61 (2001) 4520-4525
99. Salzano A., Kochiashvili N., Nergadze S.G., Khoriauli L., Smirnova A., Ruiz-Herrera A., Mondello C., and Giulotto E. Enhanced gene amplification in human cells knocked down for DNA-PKcs. DNA Repair (Amst.) 8 (2009) 19-28
100. Vanasse G.J., Halbrook J., Thomas S., Burgess A., Hoekstra M.F., Disteche C.M., and Willerford D.M. Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase. J. Clin. Invest. 103 (1999) 1669-1675
101. Difilippantonio M.J., Zhu J., Chen H.T., Meffre E., Nussenzweig M.C., Max E.E., Ried T., and Nussenzweig A. DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 404 (2000) 510-514
102. Frank K.M., Sharpless N.E., Gao Y., Sekiguchi J.M., Ferguson D.O., Zhu C., Manis J.P., Horner J., DePinho R.A., and Alt F.W. DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Mol. Cell 5 (2000) 993-1002
103. Gao Y., Ferguson D.O., Xie W., Manis J.P., Sekiguchi J., Frank K.M., Chaudhuri J., Horner J., DePinho R.A., and Alt F.W. Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature 404 (2000) 897-900
104. Lim D.S., Vogel H., Willerford D.M., Sands A.T., Platt K.A., and Hasty P. Analysis of ku80-mutant mice and cells with deficient levels of p53. Mol. Cell Biol. 20 (2000) 3772-3780
105. Difilippantonio M.J., Petersen S., Chen H.T., Johnson R., Jasin M., Kanaar R., Ried T., and Nussenzweig A. Evidence for replicative repair of DNA double-strand breaks leading to oncogenic translocation and gene amplification. J. Exp. Med. 196 (2002) 469-480
106. Zhu C., Mills K.D., Ferguson D.O., Lee C., Manis J., Fleming J., Gao Y., Morton C.C., and Alt F.W. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell 109 (2002) 811-821
107. Wright S.M., Woo Y.H., Alley T.L., Shirley B.J., Akeson E.C., Snow K.J., Maas S.A., Elwell R.L., Foreman O., and Mills K.D. Complex oncogenic translocations with gene amplification are initiated by specific DNA breaks in lymphocytes. Cancer Res. 69 (2009) 4454-4460
108. Rooney S., Sekiguchi J., Whitlow S., Eckersdorff M., Manis J.P., Lee C., Ferguson D.O., and Alt F.W. Artemis and p53 cooperate to suppress oncogenic N-myc amplification in progenitor B cells. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 2410-2415
109. Gostissa M., Ranganath S., Bianco J.M., and Alt F.W. Chromosomal location targets different MYC family gene members for oncogenic translocations. Proc. Natl. Acad. Sci. U.S.A. 106 (2009) 2265-2270
110. Sharpless N.E., Alson S., Chan S., Silver D.P., Castrillon D.H., and DePinho R.A. p16(INK4a) and p53 deficiency cooperate in tumorigenesis. Cancer Res. 62 (2002) 2761-2765
111. Rebuzzini P., Martinelli P., Blasco M., Giulotto E., and Mondello C. Inhibition of gene amplification in telomerase deficient immortalized mouse embryonic fibroblasts. Carcinogenesis 28 (2007) 553-559